StonvexLoading…
StonvexStonvexStonvexCore line items from AMBQ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $25.06M | $72.51M | $51.77M | $33.60M |
Operating Income | $-11.69M | $-39.54M | $-27.58M | $-17.54M |
Net Income | $-10.17M | $-36.46M | $-25.78M | $-16.78M |
EPS (Diluted) | $-0.50 | $-4.57 | $-5.73 | $-37.59 |
Total Assets | $259.52M | $184.68M | $186.73M | $89.16M |
Total Liabilities | $24.36M | $22.22M | $16.94M | $18.32M |
Cash & Equivalents | $204.53M | $140.28M | $146.49M | $47.51M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 21.36M | 18.32M | 18.24M | 450.68K |